highly significantp < 0.001
Within-group analyses revealed highly significant reductions in pain from baseline to Day 7 in all groups (Friedman’s test, all p < 0.001), with very large effect sizes.
Within-group analyses revealed highly significant reductions in pain from baseline to Day 7 in all groups (Friedman’s test, all p < 0.001), with very large effect sizes.